Delek US director sells 4,909 shares
Delek US Holdings director Vicky Sutil reported two open-market sales of the company’s Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Delek US Holdings director Vicky Sutil reported two open-market sales of the company’s Common Stock. On May 29, 2026, Sutil sold 1,848 shares at $45.00 per share, followed by 3,061 shares at $46.00 per share on June 1, 2026. After these transactions, Sutil directly holds 31,239 shares of Delek US Holdings Common Stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,061 | $46.00 | $141K |
| Sale | Common Stock | 1,848 | $45.00 | $83K |
Key Figures
Key Terms
open-market sale financial
Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Delek US (DK) director Vicky Sutil report?
What are Vicky Sutil’s Delek US (DK) holdings after the reported sales?
Were the Delek US (DK) insider transactions open-market sales?
Does the Delek US (DK) Form 4 show any option exercises or derivative trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.